Close Menu

Derek Lowe at In the Pipeline blogs about an online auction of "assets" from Pfizer, KV Pharmaceutical, and Universal MS Services, LLP, including mass spectrometers, assorted high performance liquid chromatography components, liquid-handling systems, tablet presses, and more — all derivatives of the "complete closure of state-of-the-art laboratories." Lowe writes, "Don't

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.